Molecular alterations pertaining to diabetic phenotype such as defects in insulin signaling leading to lack of response to insulin and subsequent hyperinsulinemia, may ultimately promote tumorigenesis via HIF1 regulation, increased glucose uptake and its utilization, making energy more readily available to afford the uncontrolled growth of tumor [101]. The gene discussed is HIF1A; the disease is Hyperinsulinemia.